logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hima Medical (03309.HK) spent 361,300 Hong Kong dollars on November 10th to buy back 200,000 shares.

date
10/11/2025
The Smart Financial News App reports that Xima Medical (03309.HK) has announced that on November 10, 2025, the company will spend 361,300 Hong Kong dollars to repurchase 200,000 shares, with a repurchase price of 1.8-1.82 Hong Kong dollars per share.
Latest
2 m ago
Tianwo Technology: planning to publicly transfer 7.1173% equity of Qinghai Haihe worth 8,537,600 yuan.
4 m ago
Zhonggong International (002051.SZ) signs a contract for a 571 million yuan hospital construction project in Iraq.
4 m ago
October Rice Fields (09676.HK) proposes the appointment of He Yang as an executive director and Guo Hong as an independent non-executive director.
7 m ago
ST Lanhuan (000929.SZ) subsidiary plans to invest no more than 65 million yuan to build a fruit juice beverage project.
7 m ago
4D Molecular Therapeutics (FDMT.US): The Q3 financial report for the year 2025 shows a revenue of $90,000, compared to $3,000 previously, with an expected value of $645,800; earnings per share are -$1.01, compared to -$0.79 previously, with an expected value of -$1.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.